Brain stimulation breakthrough? new technique targets cognitive decline in rare condition
NCT ID NCT07166432
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing a new, minimally invasive brain stimulation technique for people with cerebellar cognitive affective syndrome (CCAS), a condition that causes problems with thinking, mood, and movement. The researchers are enrolling 200 participants with Cushing's syndrome-related cerebellar atrophy. They aim to see if the stimulation improves symptoms and to understand how it works at a molecular level.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
minimally-invasive bidirectional epidural cerebellar stimulation
What this could lead to
If successful, this could point toward a new treatment for cognitive and movement problems caused by cerebellar atrophy.
What could go wrong
This is an early-stage study focused on understanding how the technique works. It is small and may not lead to a proven treatment. Risks of the procedure are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBELLAR ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Urology, Peking University First Hospital, Beijing, 100034
RECRUITINGBeijing, China
Contact Email: •••••@•••••